|
1
|
Development of peptide-based reversing agents for p-glycoprotein-mediated resistance to carfilzomib.
|
Mol Pharm
|
2012
|
0.91
|
|
2
|
Corneal antifibrotic switch identified in genetic and pharmacological deficiency of vimentin.
|
J Biol Chem
|
2011
|
0.86
|
|
3
|
A bright approach to the immunoproteasome: development of LMP2/β1i-specific imaging probes.
|
Bioorg Med Chem
|
2011
|
0.83
|
|
4
|
Revisiting the role of the immunoproteasome in the activation of the canonical NF-κB pathway.
|
Mol Biosyst
|
2012
|
0.83
|
|
5
|
A FRET-based approach for identification of proteasome catalytic subunit composition.
|
Mol Biosyst
|
2014
|
0.79
|
|
6
|
Proteasome inhibitors with pyrazole scaffolds from structure-based virtual screening.
|
J Med Chem
|
2015
|
0.77
|
|
7
|
[5-Hydroxy-3-phenyl-1-(pyridin-2-yl)pyrazol-5-olato]diphenylboron.
|
Acta Crystallogr Sect E Struct Rep Online
|
2011
|
0.75
|
|
8
|
Elucidating the catalytic subunit composition of distinct proteasome subtypes: a crosslinking approach employing bifunctional activity-based probes.
|
Chembiochem
|
2014
|
0.75
|